• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《昆明-蒙特利尔全球生物多样性框架》的一项新指标:从获取和惠益分享协议中获取非货币惠益数据。

A new indicator for the Kunming-Montreal Global Biodiversity Framework: Capturing non-monetary benefit data from access and benefit-sharing agreements.

作者信息

Nunez-Vega Genuar, Reimer Lorenz Christian, Overmann Jörg, Scholz Amber Hartman

机构信息

Science Policy and Internationalization Department, Leibniz Institute DSMZ, Technical University of Braunschweig, Braunschweig, Germany.

Department of Bioinformatics, Leibniz Institute DSMZ, Braunschweig, Germany.

出版信息

Bioscience. 2025 Feb 19;75(4):298-306. doi: 10.1093/biosci/biae132. eCollection 2025 Apr.

DOI:10.1093/biosci/biae132
PMID:40276478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12016788/
Abstract

The 2022 Kunming-Montreal Global Biodiversity Framework (KMGBF) moves international efforts to conserve biodiversity into a quantitative era. Fair and equitable benefit-sharing is one of the three objectives of the Convention on Biological Diversity, which means that to achieve the KMGBF, its parties will need to begin quantifying the benefits received from access and benefit-sharing (ABS). This mandate represents a big challenge as countries will need to begin to measure both monetary and non-monetary benefits from ABS agreements. Non-monetary benefits, in particular, can be more difficult to measure than monetary benefits, resulting in lower scientific understanding and integration of scientific results into national policy choices. In the present article, we propose a new methodology to deliver data to the KMGBF on non-monetary benefit-sharing indicators using scientific publications that cite ABS permits and put forth recommendations for improving the visibility of non-monetary benefits.

摘要

《2022年昆明-蒙特利尔全球生物多样性框架》(KMGBF)将国际生物多样性保护工作带入了一个量化时代。公平和公正的惠益分享是《生物多样性公约》的三大目标之一,这意味着为实现KMGBF,其缔约方将需要开始对从获取和惠益分享(ABS)中获得的惠益进行量化。这项任务是一项巨大的挑战,因为各国将需要开始衡量ABS协议带来的货币和非货币惠益。特别是非货币惠益,可能比货币惠益更难衡量,导致对其科学理解较低,且难以将科学成果纳入国家政策选择。在本文中,我们提出了一种新方法,利用引用ABS许可的科学出版物,向KMGBF提供关于非货币惠益分享指标的数据,并就提高非货币惠益的可见性提出建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3100/12016788/fd3ece124937/biae132fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3100/12016788/b505512cb395/biae132fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3100/12016788/4d426c8d068e/biae132fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3100/12016788/e42ba23f9944/biae132fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3100/12016788/fd3ece124937/biae132fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3100/12016788/b505512cb395/biae132fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3100/12016788/4d426c8d068e/biae132fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3100/12016788/e42ba23f9944/biae132fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3100/12016788/fd3ece124937/biae132fig3.jpg

相似文献

1
A new indicator for the Kunming-Montreal Global Biodiversity Framework: Capturing non-monetary benefit data from access and benefit-sharing agreements.《昆明-蒙特利尔全球生物多样性框架》的一项新指标:从获取和惠益分享协议中获取非货币惠益数据。
Bioscience. 2025 Feb 19;75(4):298-306. doi: 10.1093/biosci/biae132. eCollection 2025 Apr.
2
Access and Benefit Sharing Under the Nagoya Protocol-? Six Latin American Case Studies Assessing Opportunities and Risk.《名古屋议定书》下的获取与惠益分享——六个拉丁美洲案例研究:评估机遇与风险
Front Pharmacol. 2020 Jun 8;11:765. doi: 10.3389/fphar.2020.00765. eCollection 2020.
3
Operationalizing "One Health" as "One Digital Health" Through a Global Framework That Emphasizes Fair and Equitable Sharing of Benefits From the Use of Artificial Intelligence and Related Digital Technologies.通过一个强调公平和公正分享人工智能和相关数字技术应用所带来的利益的全球框架,将“One Health”付诸实践为“One Digital Health”。
Front Public Health. 2022 May 3;10:768977. doi: 10.3389/fpubh.2022.768977. eCollection 2022.
4
Including Digital Sequence Data in the Nagoya Protocol Can Promote Data Sharing.将数字序列数据纳入《名古屋议定书》有助于促进数据共享。
Trends Biotechnol. 2021 Feb;39(2):116-125. doi: 10.1016/j.tibtech.2020.06.009. Epub 2020 Jul 10.
5
Convention on Biological Diversity (CBD) and the Nagoya Protocol: Implications and Compliance Strategies for the Global Coffee Community.《生物多样性公约》(CBD)与《名古屋议定书》:对全球咖啡界的影响及合规策略
Foods. 2024 Jan 13;13(2):254. doi: 10.3390/foods13020254.
6
Balanced Options for Access and Benefit-Sharing: Stakeholder Insights on Provider Country Legislation.获取与惠益分享的平衡选项:利益相关者对提供国立法的见解
Front Plant Sci. 2019 Oct 1;10:1175. doi: 10.3389/fpls.2019.01175. eCollection 2019.
7
Implementation of the Nagoya Protocol in the European Union and in Germany.《在欧盟和德国实施<名古屋议定书>》。
Phytomedicine. 2019 Feb;53:313-318. doi: 10.1016/j.phymed.2018.10.020. Epub 2018 Oct 26.
8
Who Are Indigenous and Local Communities and What Is Traditional Knowledge for Virus Access and Benefit-sharing? A Textual Analysis of the Convention on Biological Diversity and Its Nagoya Protocol.谁是土著和地方社区,关于病毒获取与惠益分享的传统知识是什么?对《生物多样性公约》及其《名古屋议定书》的文本分析
J Law Med. 2018 Apr;25(3):707-726.
9
COVID-19 Tests the Limits of Biodiversity Laws in a Health Crisis: Rethinking "Country of Origin" for Virus Access and Benefit-sharing.新冠疫情大流行对卫生危机中的生物多样性法律提出了挑战:重新思考病毒获取和惠益分享的“起源国”。
J Law Med. 2021 Mar;28(3):684-706.
10
Benefit-Sharing by Design: A Call to Action for Human Genomics Research.设计中的利益分享:人类基因组研究的行动呼吁。
Annu Rev Genomics Hum Genet. 2024 Aug;25(1):369-395. doi: 10.1146/annurev-genom-021623-104241. Epub 2024 Aug 6.

本文引用的文献

1
Europe PMC in 2023.2023 年的 Europe PMC。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1668-D1676. doi: 10.1093/nar/gkad1085.
2
Critical Review of the Increasing Complexity of Access and Benefit-Sharing Policies of Genetic Resources for Genebank Curators and Plant Breeders-A Public and Private Sector Perspective.从公共和私营部门视角对基因库管理者和植物育种者获取遗传资源及惠益分享政策日益复杂情况的批判性审视
Plants (Basel). 2023 Aug 19;12(16):2992. doi: 10.3390/plants12162992.
3
Myth-busting the provider-user relationship for digital sequence information.
破除数字序列信息提供者-使用者关系中的迷思。
Gigascience. 2021 Dec 29;10(12). doi: 10.1093/gigascience/giab085.
4
Quantitative monitoring of nucleotide sequence data from genetic resources in context of their citation in the scientific literature.在科学文献中引用遗传资源的核苷酸序列数据的定量监测。
Gigascience. 2021 Dec 29;10(12). doi: 10.1093/gigascience/giab084.
5
Sharing and reporting benefits from biodiversity research.分享和报告生物多样性研究的成果。
Mol Ecol. 2021 Mar;30(5):1103-1107. doi: 10.1111/mec.15702. Epub 2020 Nov 6.
6
Access and Benefit Sharing Under the Nagoya Protocol-? Six Latin American Case Studies Assessing Opportunities and Risk.《名古屋议定书》下的获取与惠益分享——六个拉丁美洲案例研究:评估机遇与风险
Front Pharmacol. 2020 Jun 8;11:765. doi: 10.3389/fphar.2020.00765. eCollection 2020.
7
Balanced Options for Access and Benefit-Sharing: Stakeholder Insights on Provider Country Legislation.获取与惠益分享的平衡选项:利益相关者对提供国立法的见解
Front Plant Sci. 2019 Oct 1;10:1175. doi: 10.3389/fpls.2019.01175. eCollection 2019.